Pages that link to "Q37270464"
Jump to navigation
Jump to search
The following pages link to Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. (Q37270464):
Displaying 50 items.
- Mechanisms of Aβ Clearance and Degradation by Glial Cells (Q26741609) (← links)
- Current Research Therapeutic Strategies for Alzheimer's Disease Treatment (Q26765530) (← links)
- Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation (Q26766681) (← links)
- Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease (Q26773657) (← links)
- Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease (Q26781090) (← links)
- Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics (Q26784569) (← links)
- Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer's disease (review) (Q27001244) (← links)
- General anesthetics and β-amyloid protein (Q27010208) (← links)
- Cerebrospinal fluid and blood biomarkers in Alzheimer's disease (Q27023758) (← links)
- Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. (Q27303708) (← links)
- Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models (Q28478524) (← links)
- Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease (Q28748461) (← links)
- Amyloid β-Protein Assembly: The Effect of Molecular Tweezers CLR01 and CLR03 (Q29999197) (← links)
- ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice (Q30497102) (← links)
- The characterization of the Caenorhabditis elegans mitochondrial thioredoxin system uncovers an unexpected protective role of thioredoxin reductase 2 in β-amyloid peptide toxicity (Q30513497) (← links)
- Alzheimer's disease: clinical trials and drug development (Q33349401) (← links)
- Cross-talk of membrane lipids and Alzheimer-related proteins (Q33592538) (← links)
- Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration. (Q34048835) (← links)
- The effects of sesquiterpenes-rich extract of Alpinia oxyphylla Miq. on amyloid-β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice (Q34080245) (← links)
- Toward a comprehensive neurobiology of IGF-I. (Q34100780) (← links)
- Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain (Q34130147) (← links)
- Genetics of dementia (Q34248849) (← links)
- Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice (Q34430920) (← links)
- Dementia and Alzheimer's disease: A new direction. The 2010 Jay L. Foster Memorial Lecture (Q35394390) (← links)
- How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario (Q35569964) (← links)
- The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies. (Q35677668) (← links)
- Perinatal Asphyxia May Influence the Level of Beta-Amyloid (1-42) in Cerebrospinal Fluid: An Experimental Study on Newborn Pigs (Q35821093) (← links)
- Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ via the Autophagy Pathway (Q35837162) (← links)
- Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Aβ42 protein. (Q35838906) (← links)
- Autosomal recessive causes likely in early-onset Alzheimer disease (Q35904359) (← links)
- Engaging neuroscience to advance translational research in brain barrier biology. (Q35909313) (← links)
- The Components of Flemingia macrophylla Attenuate Amyloid β-Protein Accumulation by Regulating Amyloid β-Protein Metabolic Pathway (Q36036555) (← links)
- Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex (Q36115080) (← links)
- Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain (Q36240868) (← links)
- Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin (Q36319298) (← links)
- TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production. (Q36417516) (← links)
- Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-β-associated neuropathology in Alzheimer mice (Q36547428) (← links)
- Opposing Effects of Cucurbit[7]uril and 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose on Amyloid β25-35 Assembly. (Q36593981) (← links)
- Therapeutic Potential and Anti-Amyloidosis Mechanisms of Tert-Butylhydroquinone for Alzheimer's Disease (Q36940911) (← links)
- Amyloid Beta peptides differentially affect hippocampal theta rhythms in vitro (Q37002863) (← links)
- Cerebral β-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease (Q37025036) (← links)
- Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain (Q37326344) (← links)
- Resveratrol administration increases Transthyretin protein levels ameliorating AD features - importance of transthyretin tetrameric stability (Q37370545) (← links)
- Biological marker candidates of Alzheimer's disease in blood, plasma, and serum. (Q37617521) (← links)
- Chronic treatment with anesthetic propofol attenuates β-amyloid protein levels in brain tissues of aged mice (Q37707712) (← links)
- Alzheimer's disease genetics: current knowledge and future challenges (Q37801363) (← links)
- Endothelin receptor antagonists: Potential in Alzheimer's disease (Q37824737) (← links)
- Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential (Q37881948) (← links)
- New and emerging treatments for Alzheimer's disease. (Q37996072) (← links)
- New and emerging treatments for Alzheimer's disease. (Q38006979) (← links)